| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 155.5k | $10.76 | $1.7M | | 04/01/2023 |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 25.9k | $0.00 | $0 | | 04/01/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 3.5k | $11.12 | $39.2k | | 03/16/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 12k | $0.00 | $0 | | 03/16/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 6.6k | $0.00 | $0 | | 03/16/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.9k | $11.46 | $22.1k | | 03/16/2023 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.9k | $11.44 | $22.1k | | 09/01/2022 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 6.6k | $0.00 | $0 | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 239.8k | $11.97 | $2.9M | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 40k | $0.00 | $0 | | 09/01/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 40k | $0.00 | $0 | | 04/07/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 239.8k | $11.10 | $2.7M | | 04/07/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 5.4k | $10.98 | $59.8k | | 03/21/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 18.6k | $0.00 | $0 | | 03/21/2022 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.9k | $10.13 | $19.5k | | 03/16/2022 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 6.6k | $0.00 | $0 | | 03/16/2022 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 26.3k | $0.00 | $0 | | 09/02/2021 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 157.7k | $12.97 | $2M | | 09/02/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 18.6k | $0.00 | $0 | | 03/20/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 12k | $0.00 | $0 | | 03/20/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 157.7k | $22.89 | $3.6M | | 03/16/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 26.3k | $0.00 | $0 | | 03/16/2021 |
| 02/10/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 1.6k | $1.59 | $2.5k | | 02/08/2021 |
| 02/10/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 1.6k | $23.06 | $36.9k | | 02/08/2021 |
| 02/10/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 1.1k | $23.07 | $26.2k | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 02/08/2021 |
| 02/09/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 23.6k | $23.08 | $544k | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 02/08/2021 |
| 02/09/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 20.4k | $23.04 | $470k | | 02/08/2021 |
| 02/09/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 20.4k | $1.59 | $32.4k | | 02/08/2021 |
| 02/08/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 4.5k | $23.00 | $104.1k | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 02/08/2021 |
| 02/08/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 4.9k | $23.00 | $113.3k | | 02/08/2021 |
| 02/08/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 4.9k | $1.59 | $7.8k | | 02/08/2021 |
| 10/12/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 99.3k | $21.02 | $2.1M | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 10/09/2020 |
| 10/12/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 150.7k | $21.02 | $3.2M | | 10/09/2020 |
| 10/12/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 150.7k | $1.59 | $239.6k | | 10/09/2020 |
| 10/09/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 670 | $21.00 | $14.1k | Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013 | 10/09/2020 |
|